Cambridgeshire boy takes part in brain tumour drug trial | Cambridge Children's
Leo, diagnosed with a low-grade glioma in 2023, participates in a trial testing a new drug for pediatric low-grade gliomas, aiming to stabilize tumors and reduce long-term treatment side effects.
Reference News
Six-year-old Leo from Peterborough is the first UK participant in a global brain tumour drug trial at Cambridge University Hospitals NHS Foundation Trust. The trial aims to test a new drug's effectiveness against chemotherapy for specific brain tumour patients, offering it as a weekly liquid or capsule. Leo's mum, Corey, emphasizes the importance of contributing to research for future patients.
Leo, diagnosed with a low-grade glioma in 2023, participates in a trial testing a new drug for pediatric low-grade gliomas, aiming to stabilize tumors and reduce long-term treatment side effects.